Rat FGF-9 Protein

來源: 發(fā)布時(shí)間:2024-05-15

重組腸激酶(rEK)是一種高純度的重組牛腸激酶輕鏈片段,氨基酸序列與牛腸激酶輕鏈一致,有著和天然提取的腸激酶同樣特異的酶切位點(diǎn),切割位點(diǎn)Asp-Asp-Asp-Asp-Lys,可去除位于蛋白N-末端的融合蛋白,以除去不需要的融合標(biāo)簽,同時(shí)重組腸激酶(rEK)具有比天然酶更高的切割活性。重組腸激酶為采用重組大腸桿菌分泌表達(dá)的高純度、高活性、高特異的牛腸激酶,不含其他蛋白酶,可以在較寬pH范圍(4.5-9.5)和較寬溫度范圍內(nèi)有效切割融合蛋白,并且在各種去垢劑和變性劑存在的條件下仍具有部分活性。本品不含標(biāo)簽,由于具有極高酶切活性,酶切反應(yīng)使用量少,不影響下游蛋白應(yīng)用,可不考慮除去。產(chǎn)品信息規(guī)格100U/200U/500U/1000U/5000U產(chǎn)品性質(zhì)來源(Source)大腸桿菌表達(dá)分子量(MolecularWeight)理論值25.85kDa外觀(Appearance)澄清、無色至淡黃色液體酶濃度(EnzymeConcentration)≥5U/uL活性定義(ActivityDefinition)一個(gè)活性單位定義為25°C,12-16h,eotaxin-2還具有抑制髓樣細(xì)胞增殖的能力,髓樣細(xì)胞增殖是Eotaxin不共有的生物學(xué)功能。Rat FGF-9 Protein

Rat FGF-9 Protein,標(biāo)準(zhǔn)物質(zhì)

N-糖苷酶F(PNGaseF)是一種酰胺水解酶,經(jīng)過和平空間站伊麗莎菌克隆,主要由腦膜炎膿桿菌等革蘭氏陰性菌分泌。酵母重組表達(dá)N-糖苷酶F(比活性:750000U/mL),可以裂解由天冬酰胺連接的高甘露糖、雜合和復(fù)雜的寡糖糖蛋白。PNGaseF的切割位點(diǎn)為糖蛋白內(nèi)側(cè)N-乙酰葡萄糖胺(GlcNAc)和天冬酰氨殘基之間的酰胺鍵,同時(shí)將酶解后蛋白上的天冬氨酰轉(zhuǎn)化為天冬氨酸。本產(chǎn)品帶his標(biāo)簽,常應(yīng)用于抗體及其相關(guān)蛋白完全去糖基化。另外,我司還提供其他類型的糖苷酶,包括酵母重組表達(dá)的N-糖苷酶F,糖苷內(nèi)切酶H,糖苷內(nèi)切酶S。產(chǎn)品信息產(chǎn)品性質(zhì)中文別名(Chinesesynonym)N-糖酰胺酶F;N-糖苷酶F英文別名(Englishsynonym)PNGaseF來源(Source)酵母重組表達(dá)分子量(Molecularweight)36kDa比活性(Specificactivity)750000U/mL緩沖液組分(Buffer)20mMTris-HClpH7.5,50mMNaCl,5mMEDTA,50%GlycerolRecombinant Canine EMMPRIN/CD147 Protein,His Tagα-凝血酶(α-Thrombin)可以啟動(dòng)XIII因子和血小板,或者用作血管收縮劑。

Rat FGF-9 Protein,標(biāo)準(zhǔn)物質(zhì)

性能參數(shù)表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)CynomolgusCD27Ligand/CD70ProteinisexpressedfromHEK293withHistagattheN-terminal.ItcontainsGln39-Pro194.[Accession|G7PYU6-1]分子量大?。∕olecularWeight)TheproteinhasapredictedMWof18.4kDa.Duetoglycosylation,theproteinmigratesto60-90kDabasedonTris-BisPAGEresult.(Endotoxin)Lessthan1EUperugbytheLALmethod.純度(Purity)>95%asdeterminedbyTris-BisPAGE活性(Activity)ELISAData:ImmobilizedCynomolgusCD27Ligand,HisTagat2μg/ml(100μl/well)ontheplate.DoseresponsecurveforCynomolgus/RhesusmacaqueCD27,hFcTagwiththeEC50of70.8ng/mldeterminedbyELISA.制劑(Formulation)Lyophilizedfrom0.22μmfilteredsolutioninPBS(pH7.4).Normally8%trehaloseisaddedasprotectantbeforelyophilization.重構(gòu)方法(Reconstitution)Centrifugetubesbeforeopening.Reconstitutingtoaconcentrationmorethan100μg/mlisrecommended.Dissolvethelyophilizedproteinindistilledwater.

RecombinantBiotinylatedHumanOX40/TNFRSF4/CD134Protein(PrimaryAmineLabeling),hFcTag性能參數(shù)分子別名(Synonyms)OX40Lreceptor;CD134;TNFRSF4;Ly-70表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)BiotinylatedHumanOX40/TNFRSF4/CD134Protein(PrimaryAmineLabeling)isexpressedfromHEK293withhFctagattheC-Terminus.ItcontainsLeu29-Ala216.[Accession|P43489]分子量大小(MolecularWeight)TheproteinhasapredictedMWof46.8kDa.Duetoglycosylation,theproteinmigratesto72-75kDabasedonSDS-PAGEresult.(Endotoxin)Lessthan1EUperμgbytheLALmethod.純度(Purity)>95%asdeterminedbySDS-PAGE制劑(Formulation)Suppliedas0.22μmfilteredsolutioninPBS(pH7.4).儲(chǔ)存條件Theproductshouldbestoredat-85~-65℃for1yearfromdateofreceipt.Recommendtoaliquottheproteinintosmallerquantitieswhenfirstusedandavoidrepeatedfreeze-thawcycles.雙堿性內(nèi)切酶又稱為Kex2蛋白酶、YSCF蛋白酶,在酵母體內(nèi)Kex2蛋白酶負(fù)責(zé)加工killer toxin和α-factor的前體。

Rat FGF-9 Protein,標(biāo)準(zhǔn)物質(zhì)

Trop-2,alsoknownasepithelialglycoprotein-1antigen(EGP-1),isaproteinthatinhumansisencodedbytheTACSTD2gene.Mutationsofthisgeneresultingelatinousdrop-likecornealdystrophy,anautosomalrecessivedisordercharacterizedbyseverecornealamyloidosisleadingtoblindness.產(chǎn)品性質(zhì)別名EGP1;EGP-1;TROP2;GA733-1;gp50;T16;TACSTD2;TROP-2;M1S1;TACD2UniprotNo.P09758表達(dá)區(qū)間及表達(dá)系統(tǒng)RecombinantBiotinylatedHumanTROP-2/TACSTD2ProteinisexpressedfromHEK293cellswithHistagandAvitagattheC-terminal.ItcontainsHis27-Thr274.分子量TheproteinhasapredictedMWof30.5kDa.Duetoglycosylation,theproteinmigratesto46-55kDabasedonTris-BisPAGEresult.純度>95%asdeterminedbySDS-PAGEandHPLC活性ELISAData:ImmobilizedAnti-TROP-2Antibody,hFcTagat0.5μg/mL(100μL/well)ontheplate.DoseresponsecurveforBiotinylatedHumanTROP-2,HisTagwiththeEC50of24.1ng/mLdeterminedbyELISA.0EUper1μgoftheproteinbytheLALmethod.制劑Lyophilizedfrom0.22μmfilteredsolutioninPBS(pH7.4).Normally5%trehaloseisaddedasprotectantbeforelyophilization.甲磺酸達(dá)比加群酯是一種抗凝藥,通過競(jìng)爭(zhēng)結(jié)合凝血酶的纖維蛋白特異結(jié)合位點(diǎn),從而抑制血栓的形成。Recombinant Human MSPR/RonProtein,His Tag

26Rfa, Hypothalamic Peptide, human,純度:經(jīng)SDS-PAGE和HPLC鑒定純度大于98%。Rat FGF-9 Protein

IdeSProtease全稱免疫球蛋白G降解酶(ImmunoglubulinG-degradingenzymeofStreptococcuspyogenes,IdeS),是由人類致病菌釀膿鏈球菌(Streptococcuspyogenes)產(chǎn)生并分泌至胞外的一種半胱氨酸水解酶。該蛋白酶具有極高的底物特異性,能識(shí)別IgG,在抗體下鉸鏈區(qū)的特定位點(diǎn)進(jìn)行酶切,使IgG水解為完整的F(ab’)2片段和Fc片段。IdeS可識(shí)別人源和其他多種動(dòng)物來源的IgG,比如人、兔、猴、綿羊以及人動(dòng)物嵌合IgG等。IdeS具有獨(dú)特的底物選擇性,可以作為工具酶應(yīng)用于抗體類藥物或抗體融合蛋白藥物的結(jié)構(gòu)表征分析。本產(chǎn)品利用大腸桿菌重組表達(dá),純度高,具有良好的酶切活性,是用于表征抗體、Fc融合蛋白和抗體-藥物復(fù)合物的有價(jià)值的工具。產(chǎn)品信息規(guī)格2000U/5000U產(chǎn)品性質(zhì)中文別名(Chinesesynonym)免疫球蛋白G降解酶英文別名(Englishsynonym)IdeSProtease來源(Source)大腸桿菌表達(dá)標(biāo)簽(label)N-terminalHisTag純度(Purity)經(jīng)SDS-PAGE及HPLC分析,純度>95%分子量(Molecularweight)35.3kDa緩沖液組分(Buffer)50mM磷酸鈉,150mMNaCl(pH6.6),50%glycerolRat FGF-9 Protein